Welcome to our dedicated page for APN news (Ticker: APN), a resource for investors and traders seeking the latest updates and insights on APN stock.
Apeiron Capital Investment Corp. (APN) is a blank check company specializing in strategic business combinations, currently undergoing liquidation following its decision to terminate the proposed merger with GIO World Health, Ltd. This page provides official updates regarding shareholder redemptions, trust account distributions, and regulatory filings.
Investors and financial professionals will find verified information about public share redemption values, warrant status updates, and dissolution proceedings. The resource consolidates all material announcements including merger attempts, financial audits, and corporate governance decisions made under CEO Dr. Joel Shulman's leadership.
Key updates cover the liquidation timeline initiated August 14, 2023, with details on non-interest bearing trust account distributions and the expiration of company warrants. Content is maintained to reflect ongoing compliance requirements and final shareholder communications.
Bookmark this page for centralized access to APN's regulatory disclosures and liquidation-related announcements. While redemption processes are automated for most investors, stakeholders should monitor updates for potential regulatory changes affecting dissolution proceedings.
GIO World Health Ltd has announced a business combination agreement with Apeiron Capital Investment Corp (APNC) to take GIO public, valuing the company at a pre-money enterprise value of $250 million. Post-closing, current GIO shareholders will maintain 100% equity and approximately 80.83% ownership in the combined entity, which will be named GIO World Health Holdings, Inc. The transaction aims to provide a platform for GIO's stem cell treatments and other products. The deal is anticipated to close in the second half of 2023, pending shareholder approvals and customary conditions.
Apeiron Capital Investment Corp. (NYSE: APN U) announced on December 29, 2021, that starting December 30, holders of its IPO units can separately trade shares of Class A common stock (symbol: APN) and warrants (symbol: APN W). No fractional warrants will be issued upon separation, and the units that remain unseparated will continue trading under the symbol APN U. The Company is a blank check firm aiming for mergers or acquisitions, primarily in the financial technology, media, gaming, and wealth-advisory sectors.
Apeiron Capital Investment Corp. closed its IPO of 17,250,000 units at $10.00 each, including the full exercise of the underwriters' over-allotment option. The units began trading on the NYSE under the ticker symbol 'APNU' on November 9, 2021. Each unit comprises one share of Class A common stock and one-half of a redeemable warrant, with each whole warrant exercisable at $11.50 per share. The Company aims for business combinations mainly in financial technology, media, gaming, and wealth-advisory sectors.
Apeiron Capital Investment Corp. announced the pricing of its initial public offering (IPO) of 15,000,000 units at $10.00 per unit, set to begin trading on the NYSE under the ticker APN U on November 9, 2021. Each unit comprises one share of Class A common stock and one-half of a redeemable warrant, with whole warrants exercisable at $11.50 per share. The offering is expected to close on November 12, 2021, pending customary conditions. The company intends to focus on mergers in the FTMG sectors, while Cantor Fitzgerald serves as the offering manager.
